Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dr. Theiss Ringelblumen Salbe N is a topical herbal ointment containing a fluid extract of marigold flowers (*Calendula officinalis*). Developed and manufactured by Dr. Theiss Naturwaren GmbH, it is indicated for promoting the healing of superficial wounds and for the care of rough, stressed, or chapped skin. The active constituents of the calendula extract provide anti-inflammatory and tissue-regenerative effects, facilitating skin repair. The product has been evaluated in Phase II clinical-experimental studies to assess local skin tolerance and sensitization potential in healthy adults using the Duhring-chamber test.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dr. Theiss Ringelblumen Salbe N.